We are live on ! Find out more
FAF

Fjarde Ap-fonden Portfolio holdings

AUM $20.9B
1-Year Est. Return 36.93%
This Fund
S&P 500
This Quarter Est. Return
+9.82%
1 Year Est. Return
+36.93%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$8.14B
AUM Growth
+$472M
Cap. Flow
-$185M
Cap. Flow %
-2.28%
Top 10 Hldgs %
22.23%
Holding
635
New
20
Increased
297
Reduced
290
Closed
18

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$12.3M
2
BX icon
Blackstone
BX
+$12.2M
3
TFC icon
Truist Financial
TFC
+$11.5M
4
WTRG icon
Essential Utilities
WTRG
+$9.5M
5
LIN icon
Linde
LIN
+$9.49M

Top Sells

Rank Stock Value
1
INTC icon
Intel
INTC
+$29.1M
2
CELG
Celgene Corp
CELG
+$19.6M
3
ABT icon
Abbott
ABT
+$16.9M
4
ITW icon
Illinois Tool Works
ITW
+$16.6M
5
AMT icon
American Tower
AMT
+$14.3M

Sector Composition

Rank Sector Weight
1 Technology 21.12%
2 Financials 15.73%
3 Healthcare 14.13%
4 Communication Services 10.46%
5 Consumer Discretionary 9.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COP icon
76
ConocoPhillips
COP
$147B
$21.6M 0.27%
332,676
+21,900
+7% +$1.29M
ADP icon
77
Automatic Data Processing
ADP
$106B
$21.2M 0.26%
124,453
-6,900
-5% -$1.14M
UNP icon
78
Union Pacific
UNP
$174B
$21.2M 0.26%
117,347
-17,800
-13% -$3.05M
CB icon
79
Chubb
CB
$135B
$21.2M 0.26%
135,953
-18,500
-12% -$2.83M
TJX icon
80
TJX Companies
TJX
$174B
$21M 0.26%
344,297
-40,100
-10% -$2.37M
CME icon
81
CME Group
CME
$96.3B
$21M 0.26%
104,522
-9,400
-8% -$1.93M
EXC icon
82
Exelon
EXC
$47.2B
$20.7M 0.25%
636,997
+1,963
+0.3% +$63.6K
SYK icon
83
Stryker
SYK
$125B
$20.6M 0.25%
98,173
-3,600
-4% -$747K
TXN icon
84
Texas Instruments
TXN
$252B
$20.6M 0.25%
160,260
+2,300
+1% +$284K
ES icon
85
Eversource Energy
ES
$26.9B
$20.5M 0.25%
240,775
+50,100
+26% +$4.17M
INTU icon
86
Intuit
INTU
$86.5B
$20.4M 0.25%
77,964
-4,900
-6% -$1.28M
FISV
87
Fiserv Inc
FISV
$28.8B
$19.9M 0.24%
171,669
+2,300
+1% +$254K
ISRG icon
88
Intuitive Surgical
ISRG
$127B
$19.6M 0.24%
99,438
+2,400
+2% +$449K
TSLA icon
89
Tesla
TSLA
$1.23T
$19.2M 0.24%
689,760
+36,000
+6% +$781K
TGT icon
90
Target
TGT
$65.6B
$18.7M 0.23%
145,791
-1,500
-1% -$176K
MS icon
91
Morgan Stanley
MS
$331B
$18.5M 0.23%
361,095
-1,600
-0.4% -$75.7K
AMAT icon
92
Applied Materials
AMAT
$403B
$18.4M 0.23%
300,638
+46,300
+18% +$2.6M
SPGI icon
93
S&P Global
SPGI
$121B
$18.3M 0.23%
67,111
-10,300
-13% -$2.68M
SLB icon
94
SLB Ltd
SLB
$73.6B
$18.3M 0.22%
454,108
-40,200
-8% -$1.44M
PNC icon
95
PNC Financial Services
PNC
$99.7B
$18.2M 0.22%
114,068
-1,200
-1% -$180K
ZTS icon
96
Zoetis
ZTS
$32.4B
$18M 0.22%
136,081
-100
-0.1% -$12.4K
AGN
97
DELISTED
Allergan plc
AGN
$17.9M 0.22%
93,408
+200
+0.2% +$36.1K
BSX icon
98
Boston Scientific
BSX
$69.5B
$17.8M 0.22%
394,285
+13,900
+4% +$582K
PLD icon
99
Prologis
PLD
$135B
$17.7M 0.22%
198,779
+3,400
+2% +$301K
AMT icon
100
American Tower
AMT
$80.8B
$17.5M 0.21%
76,125
-65,743
-46% -$14.3M

Similar funds

Fjarde Ap-fonden's Q4 2019 Portfolio in Review

As of Q4 2019, Fjarde Ap-fonden held 635 positions worth $8.14B, up 6.1% from $7.67B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Fjarde Ap-fonden's Q4 2019 filing shows 20 new, 297 increased, 290 reduced and 18 closed positions. Its largest new stake was Blackstone: 236,100 shares worth $13.2M. The largest sale was Intel, an estimated $29.1M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.

  • Fjarde Ap-fonden's largest Q4 2019 buy was Blackstone: 236,100 shares worth $13.2M.
  • Fjarde Ap-fonden added most to Bristol-Myers Squibb in Q4 2019, an estimated $12.3M increase.
  • Fjarde Ap-fonden's biggest Q4 2019 reduction was Intel, cutting an estimated $29.1M.
  • Fjarde Ap-fonden fully exited Celgene Corp in Q4 2019, selling an estimated $19.6M.
  • Fjarde Ap-fonden's ten largest holdings make up 22% of its $8.14B portfolio in Q4 2019.
  • Fjarde Ap-fonden opened 20 new positions and closed 18 in Q4 2019.
  • Fjarde Ap-fonden's portfolio value rose 6.1% quarter-over-quarter to $8.14B.

Based on Fjarde Ap-fonden's 13F filing for Q4 2019, filed 10 Feb 2020.